Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX6WK5
|
||||
Drug Name |
1-Methyl-8-{[1-(methylsulfonyl)piperidin-4-yl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide
|
||||
Synonyms |
CHEMBL597753
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H32N8O4S
|
||||
Canonical SMILES |
Cn1nc(C(=O)N)c2CCc3cnc(NC4CCN(CC4)C(=O)C5CCN(CC5)S(=O)(=O)C)nc3c12
|
||||
InChI |
InChI=1S/C23H32N8O4S/c1-29-20-17(19(28-29)21(24)32)4-3-15-13-25-23(27-18(15)20)26-16-7-9-30(10-8-16)22(33)14-5-11-31(12-6-14)36(2,34)35/h13-14,16H,3-12H2,1-2H3,(H2,24,32)(H,25,26,27)
|
||||
InChIKey |
NRGPURJFHVVJFI-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Aurora kinase A | Target Info | [1587926] | ||
Glycogen synthase kinase-3 | Target Info | [1587926] | |||
KEGG Pathway | Oocyte meiosis | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Aurora B signaling | ||||
Signaling by Aurora kinases | |||||
Integrin-linked kinase signaling | |||||
PLK1 signaling events | |||||
Aurora A signalingbetacatenin_deg_pathway:Degradation of beta catenin | |||||
Canonical Wnt signaling pathway | |||||
FOXM1 transcription factor network | |||||
Class I PI3K signaling events mediated by Akt | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.